HFA Premium Access

The effectiveness of implantable cardioverter-defibrillator in preventing sudden cardiac death in patients with chronic heart failure.

Congress Presentation

About the speaker

Doctor Talgat Eskarayev

JSC "National scientific cener of oncology and transplantology", Astana (Kazakhstan)
0 follower

22 more presentations in this session

Could one-year effect of cardiac resynchronization therapy on hemodynamic parameters evaluated by impedance cardiography be predicted ?

Speaker: Mr M. Orszulak (Katowice, PL)


FDA expedited access pathway enables staged approval opportunity for baroreflex activation therapy for heart failure with reduced ejection fraction: the BeAT-HF trial

Speaker: Professor W. Abraham (Columbus, US)


A local network for refractory cardiogenic shock

Speaker: Doctor C. Sorini Dini (Siena, IT)


Long-term survival and predictors of mortality in patients supported with a left ventricular assist device as destination therapy

Speaker: Doctor C. Kapelios (Kallithea-Athens, GR)


Single center long term results of mechanical circulatory support in the netherlands

Speaker: Doctor N. de Jonge (Utrecht, NL)


Access the full session

Poster Session 3 - Devices / CRT / ICD

Speakers: Doctor T. Eskarayev, Mr M. Orszulak, Professor W. Abraham, Doctor C. Sorini Dini, Doctor C. Kapelios...

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb